Atopic dermatitis: Pathogenetic mechanisms

Clinical and Experimental Dermatology

Volumn 25, Issue 7, 2000, Pages 530-534

  Wollenberg, A ^a,b   Kraft, S ^a,b   Oppel, T ^a,b   Bieber, T ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; SUPERANTIGEN;

ANTIGEN PRESENTING CELL; APOPTOSIS; ATOPIC DERMATITIS; DELAYED HYPERSENSITIVITY; HUMAN; INCIDENCE; KERATINOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; REVIEW; SENSITIZATION; SOCIOECONOMICS;

DERMATITIS, ATOPIC; DISEASE SUSCEPTIBILITY; EOSINOPHILS; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNOGLOBULIN E; KERATINOCYTES; TH1 CELLS; TH2 CELLS;

EID: 0034486189     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2000.00699.x     Document Type: Review

References (55)

1. Neurodermitis atopica
2. What do we know about the etiopathology of the intrinsic type of atopic dermatitis?
3. Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample
4. Genetic studies of atopy and atopic dermatitis
5. Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation
6. The beta adrenergic theory of the atopic abnormality in asthma
7. Association studies on beta2-adrenoceptor polymorphisms and enhanced IgE responsiveness in an atopic population
8. The epidemiology and genetics of atopic allergy
9. Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperresponsiveness
10. Absence of linkage between 5q markers and serum IgE levels in four large atopic families
11. Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q
12. Lack of linkage between atopy and locus 11q13
13. Chromosome 11q13 and atopy underlying atopic eczema
14. Association between genetic variants of mast-cell chymase and eczema
15. Association between mast cell chymase genotype and atopic eczema: Comparison between patients with atopic eczema alone and those with atopic eczema and atopic respiratory disease
16. No evidence for an association between a variant of the mast cell chymase gene and atopic dermatitis based on case-control and haplotype-relative-risk analyses
17. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor [see comments]
18. Linkage and allelic association of atopy and markers flanking the IL4-receptor gene
19. The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction
20. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES
21. Reciprocal control of T helper cell and dendritic cell differentiation
22. The paradigm of type 1 and type 2 antigen-presenting cells. Implications for atopic allergy
23. The expanding universe of T-cell subsets: Th1, Th2 and more
24. Atopic dermatitis and other endogenous eczemas
25. Monocyte phosphodiesterase abnormalities and dysregulation of lymphocyte function in atopic dermatitis
26. Type 4 phosphodiesterase inhibitors have clinical and in vitro antiinflammatory effects in atopic dermatitis
27. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis
28. Dry skin and inflammation
29. Biophysical properties of dry atopic and normal skin with special reference to effects of skin care products
30. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin
31. High-affinity IgE receptor on eosinophils is involved in defence against parasites
32. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis
33. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia
34. Delayed eosinophil programmed cell death in vitro: A common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis
35. The CC chemokine receptor antagonist met-RANTES inhibits eosinophil effector functions
36. The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis
37. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema
38. IgE-positive Langerhans cells and Th2 allergen-specific T cells in atopic dermatitis
39. Peripheral blood dendritic cells express FceRI as a complex composed of FceRIa and FceRIg-Chains and can use this Receptor for IgE-mediated Allergen presentation
40. IgE-dependent antigen focusing by human B lymphocytes is mediated by the low-affinity receptor for IgE
41. Serum-IgE-facilitated allergen presentation in atopic disease
42. Induction of FceR2/CD23 on human epidermal Langerhans cells by human recombinant Interleukin-4 and gamma interferon
43. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI)
44. Epidermal Langerhans cells from normal human skin bind monomeric IgE via FceRI
45. Demonstration of the high-affinity IgE receptor on human Langerhans cells in normal and diseased skin
46. Human keratinocytes release the endogenous β-galactoside-binding soluble lectin eBP which binds to Langerhans cells where it modulates their binding capacity for IgE glycoforms
47. The high-affinity receptor for IgE is the predominant IgE-binding structure in lesional skin of atopic dermatitis patients
48. Phenotyping of epidermal dendritic cells - Clinical applications of a flow cytometric micromethod
49. Atopy patch test with different vehicles and allergen concentrations: An approach to standardization
50. Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients
51. Human eosinophils produce biologically active IL-12: Implications for control of T cell responses
52. Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis
53. The role of superantigens in human diseases: Therapeutic implications for the treatment of skin diseases
54. Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications
55. Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis